Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/1930
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHorton, S. B.en
dc.contributor.authorStocker, C. F.en
dc.date.accessioned2022-11-07T23:26:01Z-
dc.date.available2022-11-07T23:26:01Z-
dc.date.issued2016en
dc.identifier.citation31, (2), 2016, p. 95-102en
dc.identifier.otherRISen
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/1930-
dc.description.abstractObjective: The aim of this review is to highlight an emerging problem with anticoagulation-related complications in neonatal and paediatric ECMO, to explore for flaws in the currently recommended anticoagulation management responsible for these problems and to discuss possible strategies mitigating further escalation of the issue. Data Sources: Pertinent neonatal and paediatric literature on the topic of interest and international Extracorporeal Life Support Organisation (ELSO) registry data request. Conclusions: The international ELSO registry data reveals increasing rates of anticoagulation-related complications during neonatal and paediatric ECMO worldwide. The causes are multifactorial and the proposed solution to the problem is to match anticoagulation management to the pathophysiological complexity of haemostasis on ECMO.L6085931952016-03-01 <br />2016-03-08 <br />en
dc.language.isoenen
dc.relation.ispartofPerfusion (United Kingdom)en
dc.titleAnticoagulation strategies and difficulties in neonatal and paediatric extracorporeal membrane oxygenation (ECMO)en
dc.typeArticleen
dc.identifier.doi10.1177/0267659115590626en
dc.subject.keywordscentrifugal pumpen
dc.subject.keywordscomorbidityen
dc.subject.keywordsextracorporeal membrane oxygenation deviceen
dc.subject.keywordsextracorporeal oxygenationen
dc.subject.keywordshumanen
dc.subject.keywordsmonitoren
dc.subject.keywordsmultiple organ failureen
dc.subject.keywordsoxygenatoren
dc.subject.keywordspartial thromboplastin timeen
dc.subject.keywordspoint of care testingen
dc.subject.keywordsiloprosten
dc.subject.keywordsprothrombin timeen
dc.subject.keywordsregisteren
dc.subject.keywordsreviewen
dc.subject.keywordsthromboelastographyen
dc.subject.keywordsventricular assist deviceen
dc.subject.keywordsaminocaproic acidheparinen
dc.subject.keywordspriority journalen
dc.subject.keywordsactivated clotting timeen
dc.subject.keywordsanticoagulant therapyen
dc.subject.keywordsblood clotting parametersen
dc.relation.urlhttps://www.embase.com/search/results?subaction=viewrecord&id=L608593195&from=exporthttp://dx.doi.org/10.1177/0267659115590626 |en
dc.identifier.risid593en
dc.description.pages95-102en
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeArticle-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Sites:Children's Health Queensland Publications
Queensland Health Publications
Show simple item record

Page view(s)

38
checked on May 8, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.